A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors
Clinical trial NCT03954067 · COMPLETED
Trial details
- NCT number
- NCT03954067
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2024-04-19
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.